C-reactive protein and early mortality in acute ischemic stroke

Kathmandu University Medical Journal

Volumn 9, Issue 36, 2011, Pages 252-255

  Dewan, K R ^a   Rana, P V S ^a  

^a and Leprology   (Nepal)

Author keywords

Atherosclerosis; C reactive protein; Cardioembolic. ischemic stroke; Lacunar

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; HUMAN; LACUNAR STROKE; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MORTALITY; NEPAL; RISK FACTOR;

EID: 84862272252     PISSN: 18122027     EISSN: 18122078     Source Type: Journal    
DOI: 10.3126/kumj.v9i4.6339     Document Type: Article

References (24)

1. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
2. Torzewsky M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J et al. C reactive protein in arterial intima: role of C-reactive protein receptor dependant monocytic recruitment in atherogenesis. Atheroscler Thromb Vasc Biology 2000;20:2094-9.
3. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqat M et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for health care professionals from the Centers for Disease Control and Prevention and the American heart Association. Circulation 2003;107:499-511.
4. Rothwell PM, Howard HC, Power DA, Guntikow SA, Algra A, van Gijn J et al. Fibrinogen concentration and risk of ischemic stroke and ischemic eventsin 5113 patients with transient ischemic attacks and minor ischemic stroke. Stroke 2004;35:2300-5.
5. Di Napoli M, Schwaninger M, Campbell R, Ceccarelli E, Di Gianfilippo G, Donatti C et al. Evaluation C Reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members, Stroke 2005;36:1326-9.
6. Arvin B, Neville LF, Barone FC, Feuerstein CZ. Role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 1996;20:445-52.
7. Lagrand WK, Visser CA, Hermens WT, Niessen HWM, Verheugt FWA, Wolbink G-J et al. C-reactive protein as a cardiovascular risk factor: more than epiphenomenon. Circulation 1999;100:96-102.
8. Koening W, Sund M, Frohlich M. C- reactive protein a sensitive marker of inflammation predicts future risk of coronary heart disease in initially healthy middle aged middle aged men: resault from MONICA (Monitoring Trends and Determinants Cardiovascular Disease) Augsburg. Cohort Study 1984-1992. Circulation 1999;99:237-42.
9. Ridker PM, Hennekens CH, Buring JE, Rifal N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Eng J Med 2000;342;836-43.
10. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F. Relation of C-reactive protein to stroke, cognitive disorders and depression in the general population: systemic review and meta-analysis. Lancet Neurol 2005;4:371-80.
11. Woodward M, Lowe GDO, Campbell DJ, Colman S, Rumley A, Chalmers J et al. Association of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke 2005;36:2143-7.
12. Tanne D, Benderly M, Goldbourt U, Haim M, Tenenbaum A, Fisman EZ et al. C-reactive prtein as a predictor of Incident ischemic cerebrovascular sdtroke among patients with preexisting cardiovascular disease. Stroke 2006;37:1720-4.
13. Hansson H. Mechanisms of disease: Inflammation, atherosclerosis and coronary artery disease. N Eng J Med 2005;352:1685-95.
14. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-Reactive Protein and Outcome after Ischemic Stroke. Stroke 1999;30:981-5.
15. Di Napoli M, Gianfilippo G, Sollecito A, Bocola V. C reactive protein and outcome after first ever ischemic stroke. Stroke 2000;31:238-9.
16. Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L. Admission C - reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The 'Bergen Stroke Study' BMC. Neurology 2009;9:18-26.
17. Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999;53:126-31.
18. Clark WM, Hourihane JM.: Clinical Stroke Scales. In: Harndon RM (ed). Handbook of Neurologic Rating Scale. Demos Vermande. New York. 1997;7:161-86.
19. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A et al. Guidelines for the early management of Adukts with ischemic stroke: A guideline from the American Heart Association/American Heart Association ouncil, Clinical Cardiology Councila, Cardiovascular Radiology and intervention Counciland the Atherosclerotic Peripheral vascular Disease and Quality care Outcomes in research Interdisciplinary Groups. Stroke 2007;38:1655-711.
20. Schalla WO, Arko RJ, Thompson SE. Evaluation of a C-reactive protein latex agglutination detection test with sera from patients with sexually transmitted diseases. J Clin Micro.1984 20:1171-3.
21. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. NEJM 1999;340:448-54.
22. Glader EL, Stegmayr B, Norrving B, Teren A, Hulter-Asberg A, Wester PO et al. Sex difference in management and outcome after stroke. A Swedish national prospective study. Stroke 2003;34:1970-5.
23. Semplicini A, Maresca A, Boscolo G, Sartori M, Rochi R, Gisntin V et al. Hypertension in acute ischemic stroke. A compensatory mechanism or an additional damaging factor? Arch Intern Med 2003;163:211-6.
24. Saposnik G, O'Donell M, Fang J, Hachinski V, Kapral MK. Variable associated with 7-day, 30-day and 1year fatality after Ischemic Stroke. Stroke 2008;39:2318-24.